Patrick Soon-Shiong is a South African-born American surgeon, researcher and biotechnology entrepreneur. He invented Abraxane, a nanoparticle-based chemotherapy drug used to treat lung, breast and pancreatic cancer, drawing on his surgical and pharmacological research into targeted drug delivery. That work in reformulating cancer treatment established him as a significant figure in translational cancer research and biotechnology. He has also built a career as a businessman, including ownership of the Los Angeles Times since 2018.
Facts
Field
Field (category) Connections
Member Of
Source Patrick Soon-Shiong (Wikipedia)
Works In
Source Patrick Soon-Shiong (Wikipedia)
In the Other Atlases
Nationality
Also in Geography Atlas: the nationality of this subject.
Source Patrick Soon-Shiong (Wikidata)
Also in Geography Atlas: the nationality of this subject.
Source Patrick Soon-Shiong (Wikidata)
Sources
1. Patrick Soon-Shiong (Wikidata)
P27 (country of citizenship): United States
Q30
P19 (place of birth): Gqeberha, South Africa
Q125434
P27 (country of citizenship): South Africa
Q258
View the SourcePatrick Soon-Shiong (Wikipedia)
Works In: Medicine, Lead sentence
Patrick Soon-Shiong (; born July 29, 1952) is a South African and American businessman, researcher and surgeon who invented Abraxane, a drug used for lung, breast, and pancreatic cancer.
Member Of: University of California, Los Angeles, Lead, sentence 4
Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.